skip to content

Horizon Discovery Group

16:38 on 24/11/2017

Current Price 230.50p | Bid 230.50p | Ask 232.00p | Change 2.44%

Company Overview

Horizon Discovery Group plc is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. Horizon's proprietary gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23,000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer. These models have been adopted by c1,400 unique organisations to better understand of the genetic drivers of disease, and by Horizon in a range of services offered to customers as well as in the Company's own R&D pipeline.

Stock Details

Shares in Issue 95,062,554
Market cap £ 149.25m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 230.50p
Bid Price ? 230.50p
Ask Price ? 232.00p
Volume ? 11817
Change Today 5.50p
% Change Today 2.44%
Open 234.00p
Previous Close 230.50p
Intraday High 234.00p
Intraday Low 229.00p
52 Week High 185.50p
52 Week Low 126.50p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Sabre Aberdeen Ediston

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.